Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension | Marshall WF III expert opinion |
---|---|
Information for clinicians on investigational therapeutics for patients with COVID-19 |
Centers for Disease Control and Prevention.
1Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: A case series | Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 COVID-19 |
---|---|
Coronavirus disease 2019 COVID-19 frequently asked questions | COVID-19: Inpatient evaluation, management, and treatment |
.